110 patient evaluations for Natalizumab

Nov 30, 2008 (Started May 01, 2008)

  • Effectiveness
    Slight (for Improve mobility)
  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Effectiveness
    Slight (for stiffness/spasticity)
  • Effectiveness
    Slight (for weakness in leg(s))
  • Side effects
    Mild (UTI symptoms, stomach pain, tiredness, fear of PML)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 300 mg/15 mL Monthly
Side effects: stomach pain, UTI symptoms, tiredness, fear of PML

  • 0 helpful marks

Sep 25, 2008 (Started Dec 31, 2007)

  • Effectiveness
    Major (for General health)
  • Side effects
    Mild (headaches)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 300 mg/15 mL Monthly
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: < $25 monthly
Side effects: headaches, headaches

  • 0 helpful marks

Sep 15, 2008 (Started Jul 17, 2008)

  • Effectiveness
    Moderate (for multiple sclerosis)
  • Side effects
    Severe (generalized weakness (asthenia), nausea, stomach pain, headaches, tiredness, head pain, fear of PML)
  • Adherence
    Usually
  • Burden
    A little hard to take
Dosage: 300 mg/15 mL Monthly
Advice & Tips: Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost: $50-99 monthly
Side effects: tiredness, head pain, lethargy, fear of PML, nausea, stomach pain, headaches, generalized weakness (asthenia)

Aug 18, 2008 (Started Jul 17, 2008)

  • Effectiveness
    Can't tell (for multiple sclerosis)
  • Side effects
    Severe (generalized weakness (asthenia), nausea, headaches, tiredness, fear of PML)
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 300 mg/15 mL Monthly
Side effects: tiredness, head pain, lethargy, fear of PML, nausea, stomach pain, headaches, generalized weakness (asthenia)

  • 2 helpful marks
Last updated:
Showing 3 of 110 patient evaluations for Natalizumab